SCHEMBL20816283

SCHEMBL20816283

CCN1CCN(c2ccc(Nc3nc(Cl)nc(NC)n3)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ MAPK1 P28482 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ TDP1 Q9NUW8 3/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ HTT P42858 1/20 0.53
▸ CDK9 P50750 2/20 0.53
▸ CCNK O75909 1/20 0.53
▸ CCNA2 P20248 1/20 0.53
▸ CDK2 P24941 1/20 0.53
▸ CCND3 P30281 1/20 0.53
▸ CDK6 Q00534 1/20 0.53
▸ LMNA P02545 1/20 0.52
▸ KDM1A O60341 1/20 0.52
▸ ADRA2A P08913 1/20 0.52
▸ ADRA2B P18089 1/20 0.52
▸ ADRA2C P18825 1/20 0.52
▸ RAD52 P43351 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374566 0.84 CDK9 (0.53) CDK9CCNKCCNA2CDK2CCND3
SCHEMBL20837413 0.81 KDM1A (0.51) MAPTMEN1MAPK1KMT2ATDP1
SCHEMBL14081268 0.78 LMNA (0.82) MAPTMEN1MAPK1KMT2ASMN1; SMN2
SCHEMBL2377742 0.76 RAD52 (0.62) MAPTMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL19409829 0.76 RAD52 (0.62) MAPTSMN1; SMN2CDK9CCNKCCNA2
SCHEMBL17466591 0.74 CDK9 (0.59) MAPTSMN1; SMN2CDK9CCNKCCNA2
SCHEMBL11788144 0.73 LMNA (0.74) MAPTMEN1MAPK1KMT2ASMN1; SMN2
SCHEMBL16069915 0.73 CDK9 (0.55) MAPTSMN1; SMN2CDK9CCNKCCNA2
SCHEMBL4417817 0.73 MAPT (0.67) MAPTMEN1MAPK1KMT2ATDP1
SCHEMBL20816284 0.71 GAA (0.52) MAPTSMN1; SMN2KDM1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10624897-B2 Chlorobenzene substituted azaaryl compounds TAIPEI MEDICAL UNIVERSITY (TW) 2020-04-21 — — US disclosed
US-10624897-B2 Chlorobenzene substituted azaaryl compounds TAIPEI MEDICAL UNIVERSITY (TW) 2020-04-21 — — US disclosed
US-20190083499-A1 CHLOROBENZENE SUBSTITUTED AZAARYL COMPOUNDS TAIPEI MEDICAL UNIVERSITY (TW) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10624897-B2 Chlorobenzene substituted azaaryl compounds MKI67, CTCF, CDKN1A MAPT 4439/4885MEN1 3618/4885MAPK1 4003/4885
US-20190083499-A1 CHLOROBENZENE SUBSTITUTED AZAARYL COMPOUNDS MKI67, CTCF, CDKN1A MAPT 4439/4885MEN1 3618/4885MAPK1 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback